Infliximab safe, efficacious for refractory uveoretinitis in Behçet’s disease

Infliximab demonstrated safe and effective results for patients with refractory uveoretinitis related to Behçet’s disease, according to data published in Arthritis Research & Therapy.
“Current treatments for [Behçet’s disease (BD)] uveoretinitis include glucocorticoids, cyclosporine and other immunosuppressants,” Shigeaki Ohno, MD, PhD, of the Hokkaido University Faculty School of Medicine, Japan, and colleagues wrote. “In particular, cyclosporine exerts potent immunosuppressive activity via the suppression of T-cell function, and various

Full Story →